利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

32 条记录 (耗时 0.047 秒)

    Temporary callback system for emergency calls and methods thereof
    1.
    发明申请
    Temporary callback system for emergency calls and methods thereof 有权
    紧急呼叫的临时回拨系统及其方法

    公开(公告)号：US20130136241A1

    公开(公告)日：2013-05-30

    申请号：US13373661

    申请日：2011-11-25

    申请人： Patrick Dillon ,  Ken WU

    发明人： Patrick Dillon ,  Ken WU

    IPC分类号： H04M11/04

    CPC分类号： H04M3/5116 ,  H04M3/42195 ,  H04M2242/04

    摘要： The present disclosure relates to emergency services and more particularly, to a temporary callback system for emergency calls and methods thereof. In one illustrative embodiment, the system can include a private branch exchange (PBX) or other processing device having a pool of callback identities. When an emergency call is made, a callback identity can be temporarily assigned to the device making the call. The callback identity can provide insurance that the call is maintained. If the call between the device and answering point becomes abandoned or disconnected, the callback identity can be used to re-establish the connection. The callback identity can be released when cleared by the answering point or when a time limit expires. After being released, the callback identity can be made available to other devices that wish to make emergency calls.

    摘要翻译： 本公开涉及紧急服务，更具体地，涉及用于紧急呼叫的临时回呼系统及其方法。 在一个说明性实施例中，系统可以包括具有回叫标识池的专用小交换机（PBX）或其他处理设备。 当进行紧急呼叫时，可以将呼叫标识临时分配给进行呼叫的设备。 回拨身份可以提供保持呼叫的保险。 如果设备和应答点之间的呼叫被放弃或断开，则可以使用回呼标识来重新建立连接。 当应答点清除或时间限制到期时，可以释放回叫标识。 发布后，可以向希望进行紧急呼叫的其他设备提供回呼标识。

    Temporary callback system for emergency calls and methods thereof
    2.
    发明授权
    Temporary callback system for emergency calls and methods thereof 有权
    紧急呼叫的临时回拨系统及其方法

    公开(公告)号：US08731144B2

    公开(公告)日：2014-05-20

    申请号：US13373661

    申请日：2011-11-25

    申请人： Patrick Dillon ,  Ken Wu

    发明人： Patrick Dillon ,  Ken Wu

    IPC分类号： H04M11/00

    CPC分类号： H04M3/5116 ,  H04M3/42195 ,  H04M2242/04

    摘要： The present disclosure relates to emergency services and more particularly, to a temporary callback system for emergency calls and methods thereof. In one illustrative embodiment, the system can include a private branch exchange (PBX) or other processing device having a pool of callback identities. When an emergency call is made, a callback identity can be temporarily assigned to the device making the call. The callback identity can provide insurance that the call is maintained. If the call between the device and answering point becomes abandoned or disconnected, the callback identity can be used to re-establish the connection. The callback identity can be released when cleared by the answering point or when a time limit expires. After being released, the callback identity can be made available to other devices that wish to make emergency calls.

    摘要翻译： 本公开涉及紧急服务，更具体地，涉及用于紧急呼叫的临时回呼系统及其方法。 在一个说明性实施例中，系统可以包括具有回叫标识池的专用小交换机（PBX）或其他处理设备。 当进行紧急呼叫时，可以将呼叫标识临时分配给进行呼叫的设备。 回拨身份可以提供保持呼叫的保险。 如果设备和应答点之间的呼叫被放弃或断开，则可以使用回呼标识来重新建立连接。 当应答点清除或时间限制到期时，可以释放回叫标识。 发布后，可以向希望进行紧急呼叫的其他设备提供回呼标识。

    Chemotactic cytokine III
    4.
    发明申请
    Chemotactic cytokine III 审中-公开
    趋化性细胞因子III

    公开(公告)号：US20060073573A1

    公开(公告)日：2006-04-06

    申请号：US11244394

    申请日：2005-10-06

    申请人： Jian Ni ,  Reiner Gentz ,  Guo-Liang Yu ,  Jeffrey Su ,  Patrick Dillon

    发明人： Jian Ni ,  Reiner Gentz ,  Guo-Liang Yu ,  Jeffrey Su ,  Patrick Dillon

    IPC分类号： C12P21/02 ,  C07H21/04 ,  C07K14/52

    CPC分类号： C07K14/52 ,  A61K38/00 ,  C07K14/521 ,  Y02A50/423

    摘要： Human chemotactic cytokine III polypeptides and DNA (RNA) encoding such chemotactic cytokines and a procedure for producing such polypeptides by recombinant techniques is disclosed. Also disclosed are methods for utilizing such chemotactic cytokines for the treatment of leukemia, tumors, chronic infections, auto-immune disease, fibrotic disorders, wound healing and psoriasis. Antagonists against such chemotactic cytokines and their use as a therapeutic to treat rheumatoid arthritis, auto-immune and chronic and acute inflammatory and infective diseases, allergic reactions, prostaglandin-independent fever, cerebral ischemia, glomerulonephritis, HTLV-1 related diseases and bone marrow failure are also disclosed. Also disclosed are diagnostic assays for detecting diseases related to mutations in the nucleic acid sequences and altered concentrations of the polypeptides. Also disclosed are diagnostic assays for detecting mutations in the polynucleotides encoding chemotactic cytokine III and for detecting altered levels of the polypeptide in a host.

    摘要翻译： 公开了人类趋化性细胞因子III多肽和编码这种趋化性细胞因子的DNA（RNA）以及通过重组技术产生此类多肽的方法。 还公开了利用这种趋化性细胞因子治疗白血病，肿瘤，慢性感染，自身免疫疾病，纤维化病症，伤口愈合和牛皮癣的方法。 针对这种趋化性细胞因子的拮抗剂及其作为治疗类风湿性关节炎，自身免疫和慢性和急性炎症和感染性疾病，过敏反应，前列腺素不依赖性发烧，脑缺血，肾小球肾炎，HTLV-1相关疾病和骨髓衰竭的治疗用途 也被披露。 还公开了用于检测与核酸序列中的突变和多肽的改变的浓度相关的疾病的诊断测定。 还公开了用于检测编码趋化性细胞因子III的多核苷酸中的突变并用于检测宿主中多肽的改变水平的诊断测定。